BDBM635029 US11814367, Compound 478

SMILES F[C@@H]1C[C@H](N(C1)C(=O)Cc1ccc2ncnn2c1)C(=O)N[C@@H](c1ccccc1)c1ccc(C2CC2)c(F)c1

InChI Key InChIKey=BBHPOXMCGUGXPB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 635029   

TargetGlycogen [starch] synthase, liver(Human)
Maze Therapeutics

US Patent
LigandPNGBDBM635029(US11814367, Compound 478)
Affinity DataIC50: 6.82E+4nMAssay Description:Compounds that inhibit the hGYS2 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen [starch] synthase, muscle(Human)
Maze Therapeutics

US Patent
LigandPNGBDBM635029(US11814367, Compound 478)
Affinity DataIC50: 69nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
In DepthDetails
US Patent